… In conclusion, results from the 2-year eXpeRience registry support findings from … asthma
control when added to current therapy in patients with uncontrolled persistent allergic asthma. …

… The registry … allergic asthma enrolled in this observational registry and included in the first
interim analysis are reported here, including demographics, asthma disease history, asthma …

… In the European Union (EU), omalizumab is indicated as add-on treatment for uncontrolled
severe allergic asthma unresponsive to high-dose ICS plus a LABA (Citation3). According to …

… Our results are consistent with data from 11 national registries for severe asthma, which
could show that in practice; however, a significant proportion of patients with severe asthma are …

… or Churg-Strauss syndrome in the eXpeRience registry, but we believe that clinicians
attempting OCS reduction or withdrawal in patients with allergic asthma should be aware of this. …

… The current study was a post-hoc analysis of the global eXpeRience registry. … We did not
register any case of worsening asthma during the study period (Figure 3). Thus in contrast to …

… persistent allergic asthma. The current analysis of data from the eXpeRience registry focuses
… The results of this analysis of eXpeRience registry data suggest that add-on treatment with …

… with uncontrolled severe persistent allergic asthma. There has … We collected data from our
severe asthma registry on … life experience of omalizumab in a tertiary severe asthma centre …

… Sixty patients with severe persistent allergic asthma from 5 South-… , severe asthma
exacerbations rate, level of asthma control (… persistent allergic asthma in practice: experience …

… Furthermore, patients with severe asthma experience severe … Registry evaluated the efficacy
and tolerability of omalizumab in patients with allergic asthma [48] and non-atopic asthma …